Insiders · COUR

Carmen Chang

Director at Coursera, Inc. (COUR) since October 2021

Carmen Chang has filed 34 insider reports with the SEC since March 2021, as director at Coursera, Inc. (COUR), 10% owner at Korro Bio, Inc. (KRRO) and 10% owner at Trevi Therapeutics, Inc. (TRVI) and at 11 more companies. In the last 12 months Carmen Chang bought $17.3M of stock on the open market. The latest filing, on June 15, 2026, reports grant or award at Coursera, Inc. (COUR).

Filings
34
Companies
14
Bought on market
$44.1M
Sold on market
$1.29M

Companies where Carmen Chang is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Coursera, Inc. logo
COUR
Coursera, Inc.
Directorsince October 2021122,520$14.5K$3.55Jun 15, 2026
Korro Bio, Inc. logo
KRRO
Korro Bio, Inc.
10% ownersince November 2023$3.3M$14.67$12.32-16%Mar 13, 2026
Trevi Therapeutics, Inc. logo
TRVI
Trevi Therapeutics, Inc.
10% owner$6.8M$1.90$13.51+611%Feb 13, 2026
SpyGlass Pharma, Inc. logo
SGP
SpyGlass Pharma, Inc.
10% owner$15M$16.00$31.435+96%Feb 11, 2026
NeueHealth, Inc. logo
NEUE
NeueHealth, Inc.
Director, 10% owner$26.4KOct 6, 2025
MBX Biosciences, Inc. logo
MBX
MBX Biosciences, Inc.
10% owner$8M$16.00$53.10+232%Sep 18, 2024
Bright Health Group Inc. logo
BHG
Bright Health Group Inc.
10% ownerDec 21, 2023
Savara Inc logo
SVRA
Savara Inc
10% ownersince March 2021$1,000K$3.00$4.48+49%Jul 19, 2023
Mirum Pharmaceuticals, Inc. logo
MIRM
Mirum Pharmaceuticals, Inc.
10% owner135$91.95Jun 15, 2023
Akouos, Inc. logo
AKUS
Akouos, Inc.
10% ownerDec 2, 2022
Genocea Biosciences, Inc. logo
GNCA
Genocea Biosciences, Inc.
10% owner$751KMay 26, 2022
Metacrine, Inc. logo
MTCR
Metacrine, Inc.
10% owner$494KDec 27, 2021
Marker Therapeutics, Inc. logo
MRKR
Marker Therapeutics, Inc.
10% owner$10M$1.75$0.8366-52%Mar 18, 2021
Regulus Therapeutics Inc. logo
RGLS
Regulus Therapeutics Inc.
InsiderMar 17, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Carmen Chang.

Compare Carmen Chang with

Other insiders at the same companies

Questions about Carmen Chang

What is Carmen Chang's role at Coursera, Inc.?
Carmen Chang reports to the SEC as director at Coursera, Inc. (COUR), according to the latest filing on June 15, 2026. Carmen Chang has also filed as 10% owner at Korro Bio, Inc. (KRRO), 10% owner at Trevi Therapeutics, Inc. (TRVI), 10% owner at SpyGlass Pharma, Inc. (SGP) and director and 10% owner at NeueHealth, Inc. (NEUE).
How many shares does Carmen Chang own?
After the latest filing that states it, Carmen Chang directly owned 122,520 shares of Coursera, Inc. (COUR) and 135 shares of Mirum Pharmaceuticals, Inc. (MIRM). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Carmen Chang bought or sold stock recently?
The most recent open-market purchase was on March 10, 2026: bought 207,100 shares of Korro Bio, Inc. (KRRO) for $2.3M at an average of $11.11. The most recent open-market sale was on October 2, 2025: sold 3,915 shares of NeueHealth, Inc. (NEUE) for $26.4K at an average of $6.75.
How do I get alerts when Carmen Chang files?
Follow Carmen Chang on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Carmen Chang (SEC CIK 0001746342). Totals count each trade once, skipping amendments whose original is on file, from Mar 16, 2021 on. View on SEC EDGAR